<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01190722</url>
  </required_header>
  <id_info>
    <org_study_id>201001HV</org_study_id>
    <nct_id>NCT01190722</nct_id>
  </id_info>
  <brief_title>A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain</brief_title>
  <official_title>A Randomized Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a
      better patients assessed overall satisfaction when used for pain management after elective
      hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs
      (NSAIDs).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the present study is to compare patients' satisfaction with pain medication during
      the first 7 first postoperative days following elective hallux valgus surgery in general
      anaesthesia between etoricoxib and diclofenac in a prospective randomised double-blind study
      design.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study site was closed down
  </why_stopped>
  <start_date type="Actual">November 10, 2010</start_date>
  <completion_date type="Actual">December 12, 2010</completion_date>
  <primary_completion_date type="Actual">December 11, 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patients Global Evaluation of Study Medication</measure>
    <time_frame>postoperative day 1-6</time_frame>
    <description>Patients self-assessment of global satisfaction with pain medication</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hallux Valgus</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>etoricoxib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active study drug, coxib</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active traditional NSAID control</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoricoxib</intervention_name>
    <description>120 mg once daily for the 1st 6 postoperative days</description>
    <arm_group_label>etoricoxib</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>50 mg oral 3 times daily the 1st 6 postoperative days</description>
    <arm_group_label>diclofenac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiology (ASA) physiological class 1-2 patients

          -  aged 18-65 years

          -  scheduled for elective hallux valgus surgery in general anesthesia

        Exclusion Criteria:

          -  NSAID allergy

          -  liver disease

          -  renal disease

          -  uncontrolled cardiovascular disease

          -  Lithium therapy

          -  chronic pain

          -  regular analgesia use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Jakobsson, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <removed_countries>
    <country>Sweden</country>
  </removed_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2010</study_first_submitted>
  <study_first_submitted_qc>August 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2010</study_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Jan Jakobsson</investigator_full_name>
    <investigator_title>Adj. Professor</investigator_title>
  </responsible_party>
  <keyword>Day case surgery</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>NSAIDs</keyword>
  <keyword>Coxibs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hallux Valgus</mesh_term>
    <mesh_term>Bunion</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Etoricoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

